Nevertheless, given the above and in the introduction described characteristics of CXCL16, we suppose that its functions as potent adhesion molecule, chemoattractant and mediator of systemic inflammatory response lead to metabolic disorders and subsequently organ dysfunctions in cardiac surgery patients. Here, CXCL16 is linked to metabolic disease.